Wednesday, August 12, 2026

Detroit man pleads guilty to fentanyl and cocaine trafficking in Pittsburgh federal court

Michael Appleton of Detroit pleaded guilty in Pittsburgh federal court to fentanyl and cocaine trafficking charges. Sentencing is set for
X / Twitter
LinkedIn
Print

A Detroit resident pleaded guilty on July 23 to trafficking fentanyl and cocaine, according to United States Attorney Troy Rivetti.

Michael Appleton, 44, entered his plea before United States District Judge W. Scott Hardy for possessing with intent to distribute 40 grams or more of fentanyl and a quantity of cocaine on May 19, 2023.

Judge Hardy scheduled sentencing for December 1, 2026. The law provides for a total sentence of not less than five years and up to forty years in prison, a fine of up to $5 million, or both. Under the federal Sentencing Guidelines, the actual sentence imposed will be based upon the seriousness of the offense and Appleton’s prior criminal history, if any.

Assistant United States Attorney Craig W. Haller is prosecuting the case on behalf of the government.

The Federal Bureau of Investigation, Mercer County Drug Task Force, and Pennsylvania Office of Attorney General conducted the investigation that led to Appleton’s prosecution.

Filed Under

Share This Story

X / Twitter
LinkedIn
Email
Print

Advertisement

300 × 250

Related

DEA Details Ongoing Operations Against CJNG Cartel

Daily Dispatch

The morning briefing on federal government — delivered to your inbox before 7 AM.

Advertisement

300 × 120

More from Defense

Washington National Guard Continues Statewide Wildfire Response

The Washington National Guard continued deploying air and ground assets across the state on Aug. 10 as multiple wildfires burned simultaneously in the Pacific Northwest. Federal active-duty forces from Joint...

OCC Signals Push to Revive New Bank Charter Applications

The Office of the Comptroller of the Currency announced on Aug. 11 that it will prioritize new bank charter applications as part of a “community bank comeback” initiative. The effort...

FDA Approves First Oral PCSK9 Inhibitor to Lower Cholesterol

The FDA approved the first oral PCSK9 inhibitor for lowering LDL cholesterol in adults on July 17, removing a major barrier to broader use of the most powerful class of...